ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1631

Assessment of the Repeatability and Convergent Validity with Dermal Collagen of High Frequency Ultrasound in Systemic Sclerosis

Victoria Flower1, Shaney Barratt 2, Darren Hart 3, Amanda Mackenzie 4, Jacqueline Shipley 3, Stephen Ward 4 and John Pauling 1, 1Department of Rheumatology, Royal National Hospital of Rheumatic Diseases, Royal United Hospitals NHS Foundation Trusts, Bath, England, United Kingdom, 2North Bristol NHS Trust, Bristol, England, United Kingdom, 3Department of Clinical Measurement, Royal National Hospital for Rheumatic Diseases, Royal United Hospitals NHS Trust, Bath, England, United Kingdom, 4Centre for Therapeutic Innovation & Department of Pharmacy and Pharmacology, University of Bath, Bath, England, United Kingdom

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: skin fibrosis and collagen, Systemic sclerosis, Ultrasound

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 11, 2019

Title: Systemic Sclerosis & Related Disorders – Clinical Poster II

Session Type: Poster Session (Monday)

Session Time: 9:00AM-11:00AM

Background/Purpose: There have been a number of recent negative clinical trials of SSc utilising the modified Rodnan Skin Score. High Frequency Ultrasound (HFUS) allows objective quantitative and qualitative assessment of dermal pathology and could be a useful surrogate measure of skin involvement in Systemic sclerosis (SSc). No previous studies have examined the convergent validity between HFUS features and dermal collagen in SSc. The repeatability of HFUS warrants further assessment before this method can be accepted in clinical practice. This study aims to assess the repeatability and convergent validity of HFUS parameters with dermal collagen deposition in SSc.

Methods: Fifty-three patients with SSc meeting ACR/EULAR 2013 criteria and 15 healthy controls (HC) underwent HFUS assessment of skin thickness (ST), echogenicity (as a reflection of cutaneous oedema) and Shear Wave Elastography (demonstrating skin stiffness, SWE) at the middle finger, hand, distal forearm and abdomen. Ten SSc patients and 10 HC underwent skin biopsies taken from the distal forearm. Dermal collagen was determined using Masson’s Trichrome stain.

Results: Strong positive correlations were found between dermal collagen quantification and both ST (Spearman’s rank correlation coefficient, ρ = +0.697, p=0.025) and SWE (ρ = +0.709, p=0.022) at the forearm in SSc, but not with echogenicity. Multiple linear regression analysis confirmed ST and SWE as significant predictors of localised skin collagen deposition in SSc (R2 = 0.876). ST and SWE were highly reproducible across all 4 regions of interest for the combined cohort (SSc and HC combined) with Intra-class Correlation Coefficients (ICC) of 0.946-0.978 and 0.953-0.973 respectively (Table 1). Echogenicity reproducibility was good, but weaker than ST and SWE (ICC 0.648-0.865).

Conclusion: We have demonstrated for the first time that ST and SWE on HFUS reflect collagen deposition in affected SSc skin. However, whilst low echogenicity is felt to reflect cutaneous oedema, increasing echogenicity does not accurately reflect fibrosis. HFUS parameters were highly reproducible although notably more so for ST and SWE than echogenicity. Our findings strongly support the use of ST and SWE in particular as a surrogate marker for skin fibrosis in clinical trials.


Disclosure: V. Flower, None; S. Barratt, None; D. Hart, None; A. Mackenzie, None; J. Shipley, None; S. Ward, None; J. Pauling, Boehringer Ingelheim, 5, Chugai Roche, 9.

To cite this abstract in AMA style:

Flower V, Barratt S, Hart D, Mackenzie A, Shipley J, Ward S, Pauling J. Assessment of the Repeatability and Convergent Validity with Dermal Collagen of High Frequency Ultrasound in Systemic Sclerosis [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/assessment-of-the-repeatability-and-convergent-validity-with-dermal-collagen-of-high-frequency-ultrasound-in-systemic-sclerosis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/assessment-of-the-repeatability-and-convergent-validity-with-dermal-collagen-of-high-frequency-ultrasound-in-systemic-sclerosis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology